Literature DB >> 24470636

Statins for the primary prevention of cardiovascular disease.

Shah Ebrahim1, Fiona C Taylor, Peter Brindle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24470636     DOI： 10.1136/bmj.g280

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Cardiovascular risk assessment and lipid modification: NICE guideline.

Authors:  Martin Duerden; Norma O'Flynn; Nadeem Qureshi
Journal:  Br J Gen Pract       Date:  2015-07       Impact factor: 5.386

2.  Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.

Authors:  Martin Bødtker Mortensen; Erling Falk; Dong Li; Khurram Nasir; Michael J Blaha; Veit Sandfort; Carlos Jose Rodriguez; Pamela Ouyang; Matthew Budoff
Journal:  JACC Cardiovasc Imaging       Date:  2017-07-25

Review 3.  What an anticardiovascular diet should be in 2015.

Authors:  David R Jacobs; Linda C Tapsell
Journal:  Curr Opin Lipidol       Date:  2015-08       Impact factor: 4.776

4.  Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study.

Authors:  Karen Ho; Kris M Jamsen; J Simon Bell; Maarit Jaana Korhonen; Kevin P Mc Namara; Dianna J Magliano; Danny Liew; Taliesin E Ryan-Atwood; Jonathan E Shaw; Susan Luc; Jenni Ilomäki
Journal:  Eur J Clin Pharmacol       Date:  2018-07-19       Impact factor: 2.953

5.  Patient beliefs and attitudes to taking statins: systematic review of qualitative studies.

Authors:  Angela Ju; Camilla S Hanson; Emily Banks; Rosemary Korda; Jonathan C Craig; Tim Usherwood; Peter MacDonald; Allison Tong
Journal:  Br J Gen Pract       Date:  2018-06       Impact factor: 5.386

6.  Decision Aids: The Effect of Labeling Options on Patient Choices and Decision Making.

Authors:  James G Dolan; Olena A Cherkasky; Nancy Chin; Peter J Veazie
Journal:  Med Decis Making       Date:  2015-07-30       Impact factor: 2.583

Review 7.  Pleiotropic effects of statins: new therapeutic targets in drug design.

Authors:  Onkar Bedi; Veena Dhawan; P L Sharma; Puneet Kumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-05       Impact factor: 3.000

Review 8.  Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter.

Authors:  Naina Mohamed Pakkir Maideen; Gobinath Manavalan; Kumar Balasubramanian
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-06       Impact factor: 3.565

9.  Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.

Authors:  Warren Stevens; Desi Peneva; Jim Z Li; Larry Z Liu; Gordon Liu; Runlin Gao; Darius N Lakdawalla
Journal:  BMC Health Serv Res       Date:  2016-05-10       Impact factor: 2.655

10.  Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data.

Authors:  Aidan G O'Keeffe; Irwin Nazareth; Irene Petersen
Journal:  Clin Epidemiol       Date:  2016-05-27       Impact factor: 4.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.